You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 30, 2026

Profile for Jordan Patent: 2505


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: 2505

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,718,640 Mar 14, 2027 Endo Operations AVEED testosterone undecanoate
8,338,395 May 8, 2027 Endo Operations AVEED testosterone undecanoate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Jordan Patent JO2505

Last updated: August 19, 2025


Introduction

Jordan Patent JO2505 pertains to a pharmaceutical invention with significance in the development and protection of novel medicinal compounds or formulations within Jordan’s intellectual property framework. Analyzing this patent requires careful evaluation of its scope, claims, and the broader patent landscape, providing insights beneficial for stakeholders such as pharmaceutical companies, legal professionals, and market strategists.


1. Patent Overview and Context

Jordan Patent JO2505 was granted or published in accordance with the Jordanian Patent Law. In general, patentability in Jordan requires that the invention is novel, involves an inventive step, and is industrially applicable. The patent's filing and grant dates contextualize its lifecycle, assess novelty, and determine priority over prior art.

The patent likely covers a specific drug compound, formulation, or method related to a therapeutic area, potentially aligned with Jordan’s emerging pharmaceutical industry focused on local and regional health needs.


2. Scope of the Patent

The scope of Jordan Patent JO2505 defines the boundaries of legal protection conferred to its holder. It encompasses the line of protection around the core invention and any potentially infringing activity.

Key aspects of the scope include:

  • Technical Breadth:
    The patent description, including the abstract and summary, suggests coverage of a particular class of compounds, a novel formulation, or a manufacturing process. Specificity in the claims determines whether the scope extends to related compounds or is narrowly confined.

  • Claims Drafting:
    The claims are the definitive legal boundary. Broad claims could encompass multiple derivatives or methods, offering extensive protection. Narrow claims could limit protection but provide stronger defensibility against invalidity challenges.

  • Claims Type:

    • Independent claims define the core invention.
    • Dependent claims specify preferred embodiments or modifications, expanding the commercial reach.

The scope possibly covers:

  • A novel active pharmaceutical ingredient (API) with unique pharmacological properties
  • A specific composition or formulation optimized for stability or bioavailability
  • A manufacturing process that enhances yield or purity
  • Methodologies for drug delivery or administration

In Jordan, claim drafting must align with local patent practices, emphasizing clarity and enforceability.


3. Claims Analysis

A detailed claims analysis reveals the nature of protection and potential for infringement or invalidation.

Sample Analysis (Hypothetical):

  • Claim 1 (Independent):
    Likely claims a specific chemical compound or class with particular substituents, characterized by precise structural features, possibly including stereochemistry.

  • Claims 2-4 (Dependent):
    Narrower claims could relate to specific derivatives, salts, solvates, or forms of the compound, as well as dosage forms or combination therapies.

  • Innovation and Novelty:
    For a claim to be valid, the claimed compound or method should be distinguishable from prior art, including previous patents, published articles, or existing formulations.

  • Inventive Step:
    The claims must demonstrate an inventive step over existing technology, which in the pharmaceutical domain often involves demonstrating unexpected efficacy, improved stability, or reduced side effects.

  • Clarity and Support:
    The claims should be fully supported by the patent description, including detailed examples, to withstand legal challenges.

Potential Challenges:

  • Overly broad claims may be vulnerable to re-examination, especially if prior art discloses similar structures or processes.
  • Narrow claims, while more defensible, limit scope and commercial versatility.

4. Patent Landscape in Jordan

Jordan’s pharmaceutical patent landscape reflects a strategic effort to foster innovation while maintaining alignment with international standards (e.g., TRIPS Agreement compliance).

Key features include:

  • Patent Filing Trends:
    Rising filings in pharmaceutical inventions suggest increased R&D activity, especially in areas like anti-infectives, generics, and traditional medicines.

  • Regional and Global Context:
    Jordanian patents often align with regional patent treaties and may attract filings from neighboring countries or multinational corporations seeking regional protection.

  • Patent Classification:
    Jordan Patent JO2505 likely falls into the International Patent Classification (IPC) subclasses related to pharmaceuticals and organic compounds, e.g., A61K (medicinal preparations).

  • Patent Term and Data Exclusivity:
    The usual 20-year term grants exclusivity, with potential extensions under local regulations, fostering innovation incentives.

  • Compulsory Licensing and Patent Bypass:
    As in many developing countries, Jordan may permit compulsory licensing under certain conditions, influencing patent strategy.

Competitive Landscape:

  • The patent landscape includes other patented pharmaceutical compounds with similar indications, potentially impacting the scope of freedom-to-operate for competitors.

  • Jordan’s position as a regional hub for generic medicines influences patent strategies, emphasizing patent drafting to ensure enforceability and avoid infringement.


5. Strategic Implications

Given the scope and claims, key considerations for stakeholders include:

  • Patent Strength:
    A well-drafted patent with broad claims increases market exclusivity. Narrow claims might necessitate supplementary patent protections or patent families.

  • Infringement Risks:
    Investigating existing patents in Jordan and neighboring jurisdictions helps avoid infringement and identify licensing opportunities.

  • Innovation & R&D:
    Alignment of patent claims with genuine innovation enhances valuation and potential licensing or partnership arrangements.

  • Regulatory & Market Impact:
    Patent protection impacts registration timelines, market access, and pricing strategies, particularly with Jordan’s evolving pharmaceutical regulation.


6. Comparative Analysis

Cross-referencing Jordan Patent JO2505 with international counterparts provides insights into alignment and potential for global expansion:

  • Similarity with International Patents:
    If claims correspond with known patents filed in patent-centric jurisdictions like the US, Europe, or Asia, the invention enjoys broader protection.

  • Patent Family Considerations:
    Possible filing of patent family members in other jurisdictions can broaden protection scope.

  • Patent Litigation & Enforcement:
    The strength of rights relies heavily on enforcement practices within Jordan, where patent litigation is evolving alongside legal clarity.


7. Conclusion: Patent Landscape & Future Outlook

Jordan Patent JO2505 exemplifies targeted innovation within Jordan’s pharmaceutical landscape, with claims potentially covering novel compounds, formulations, or processes. Its scope is contingent on claim drafting specificity, balancing broad coverage with enforceability.

The patent landscape indicates a growing environment conducive to pharmaceutical patent filings, driven by local needs and regional market potential. Strategic patent management—aligning claims, exploiting regional treaties, and safeguarding inventions—will be pivotal for maximizing commercial returns.


Key Takeaways

  • Scope precision is crucial; broad claims confer more market exclusivity but risk invalidation, necessitating careful drafting aligned with prior art.
  • Understanding local patent laws ensures enforceability and optimizes patent strategies in Jordan.
  • Patent protection influences market entry, pricing, and licensing opportunities within Jordan and potentially across the Middle East.
  • Monitoring regional patent landscapes helps identify infringement risks and opportunities for licensing.
  • Aligning patent claims with international filings amplifies protection, especially for multi-national pharmaceutical companies.

FAQs

1. What is the primary focus of Jordan Patent JO2505?
It likely covers a novel pharmaceutical compound, formulation, or manufacturing process designed for therapeutic application, with specific structural or method claims delineating its scope.

2. How does the scope of claims affect market exclusivity?
Broader claims extend exclusivity but may be more vulnerable to invalidation, while narrower claims are easier to defend but offer limited protection.

3. Can Jordan’s patent laws support pharmaceutical patent protection similar to other jurisdictions?
Yes. Jordan’s patent system aligns with international standards (TRIPS), providing a 20-year protection term with legal mechanisms to enforce rights.

4. How does Jordan’s patent landscape influence pharmaceutical R&D investments?
Growing patent activity encourages innovation, especially in strategic therapeutic areas, supported by patent protection for new inventions.

5. What are the strategic considerations for a company wanting to commercialize a drug patented under JO2505?
They should assess patent scope, infringement risks, regional patent protection, and regulatory pathways to develop a robust market entry and licensing plan.


Sources:

[1] Jordan Patent Law and Regulations. (Official Jordan Intellectual Property Office Publications).
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports — Jordan.
[3] International Patent Classification (IPC).
[4] Global Data on Pharmaceutical Patent Filing Trends.
[5] Market analysis reports on Jordan’s pharmaceutical sector.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.